Mouse Anti-TOR1A Recombinant Antibody (583CT1.1.3) (CBMAB-D2345-YC)
Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Biological Process chaperone cofactor-dependent protein refolding Source:InterPro
Biological Process chaperone-mediated protein folding Source:UniProtKB1 Publication
Biological Process ER-associated misfolded protein catabolic process Source:UniProtKB
Biological Process intermediate filament cytoskeleton organization Source:UniProtKB1 Publication
Biological Process neuron projection development Source:UniProtKB2 Publications
Biological Process nuclear envelope organization Source:UniProtKB
Biological Process nuclear membrane organization Source:UniProtKB
Biological Process organelle organization Source:UniProtKB
Biological Process positive regulation of synaptic vesicle endocytosis Source:UniProtKB1 Publication
Biological Process protein deneddylation Source:UniProtKB1 Publication
Biological Process protein localization to nucleus Source:UniProtKB1 Publication
Biological Process regulation of dopamine uptake involved in synaptic transmission Source:UniProtKB1 Publication
Biological Process regulation of protein localization to cell surface Source:GO_Central1 Publication
Biological Process response to oxidative stress Source:Ensembl
Biological Process synaptic vesicle membrane organization Source:UniProtKB1 Publication
Biological Process synaptic vesicle transport Source:UniProtKB1 Publication
Biological Process wound healing, spreading of cells Source:UniProtKB
Nucleus membrane
Cell projection, growth cone
Cytoplasmic vesicle membrane
Cytoplasmic vesicle, secretory vesicle
Cytoplasmic vesicle, secretory vesicle, synaptic vesicle
Cytoplasm, cytoskeleton
Upon oxidative stress, redistributes to protusions from the cell surface (By similarity).
Peripherally associated with the inner face of the ER membrane, probably mediated by the interaction with TOR1AIP1. The association with nucleus membrane is mediated by the interaction with TOR1AIP2.
A primary torsion dystonia, and the most common and severe form. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. Dystonia type 1 is characterized by involuntary, repetitive, sustained muscle contractions or postures involving one or more sites of the body, in the absence of other neurological symptoms. Typically, symptoms develop first in an arm or leg in middle to late childhood and progress in approximately 30% of patients to other body regions (generalized dystonia) within about five years. 'Torsion' refers to the twisting nature of body movements observed in DYT1, often affecting the trunk. Distribution and severity of symptoms vary widely between affected individuals, ranging from mild focal dystonia to severe generalized dystonia, even within families.
Arthrogryposis multiplex congenita 5 (AMC5):
A form of arthrogryposis multiplex congenita, a developmental condition characterized by multiple joint contractures resulting from reduced or absent fetal movements. AMC5 is an autosomal recessive form characterized by severe congenital contractures, developmental delay, strabismus and tremor.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon
Submit a review
Loading...
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us

